Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2319 |
Acotiamide monohydrochloride trihydrate
Acotiamide hydrochloride,YM-443 HCl,盐酸阿考替胺,Z-338 HCl |
AChE | Neuroscience |
Acotiamide monohydrochloride trihydrate (Z-338 HCl) 是一种首创的、具有口服活性的胃肠动力药。它通过促毒蕈碱受体拮抗作用和乙酰胆碱酯酶(AChE)抑制作用增强肠神经元释放的乙酰胆碱,从而增强胃排空和胃部适应性,有潜力用于功能性消化不良的研究。 | |||
T1552L |
Itopride free base
HSR803,HSR-803,Itopride hydrochloride,HSR 803 |
||
Itopride HCl is an AChE inhibitor and dopamine D2 receptor antagonist. It inhibits lower esophageal sphincter relaxation. It also used to treat functional dyspepsia and gastroesophageal reflux disease | |||
T70122 |
Acotiamide Methyl Ether
|
||
Acotiamide Methyl Ether is a metabolite of Acotiamide -- an acetylcholinesterase inhibitor which has been shown to stimulate gastric motility and improve gastric motility dysfunction in rats. Acotiamide Hydrochloride has also been shown to improve meal-related symptoms of functional dyspepsia. | |||
TP2403 |
Recanaclotide
IW 9179,IW-9179,IW9179 |
||
Recanaclotide can be used to treat Gastroparesis, Functional Dyspepsia, and Other Gastrointestinal Disorders. | |||
T69152 |
Bromopride hydrochloride
|
||
Bromopride hydrochloride is the salt form of Bromopride, a dopamine D2 receptor blocker. Bromopride exerts is a gastrointestinal prokinetic exploited clinically for the management of motor disorders of the upper gastrointestinal tract, including functional dyspepsia, gastric stasis of various origins and emesis. | |||
T22230 |
Acotiamide
|
||
Acotiamide 是一种具有口服活性、选择性和可逆性的乙酰胆酶碱酯 (AChE) 抑制剂,IC50值为1.79 μM。Acotiamide 是一种胃促动力剂,可增强胃收缩性并加速胃排空延迟。Acotiamide 可用于胃动力障碍的功能性消化不良及肠道炎症的研究。 | |||
T63237 |
Acotiamide hydrochloride
|
||
Acotiamide hydrochloride 是选择性的、口服具有活力的、可逆的乙酰胆酶碱酯 (AChE) 抑制剂 (IC50: 1.79 μM),能够提高胃收缩性,加速胃排空延迟,能够用于研究胃动力障碍的功能性消化不良及肠道炎症。 |